336 related articles for article (PubMed ID: 27167265)
1. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
[TBL] [Abstract][Full Text] [Related]
2. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of dose enhancement in presence of gold nanoparticles in eye brachytherapy by
Rezaei H; Zabihzadeh M; Ghorbani M; Goli Ahmadabad F; Mostaghimi H
Australas Phys Eng Sci Med; 2017 Sep; 40(3):545-553. PubMed ID: 28509080
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
7. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
Melhus CS; Rivard MJ
Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
[TBL] [Abstract][Full Text] [Related]
8. Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations.
Jones BL; Krishnan S; Cho SH
Med Phys; 2010 Jul; 37(7):3809-16. PubMed ID: 20831089
[TBL] [Abstract][Full Text] [Related]
9. Investigation of gold nanoparticle effects in brachytherapy by an electron emitter ophthalmic plaque.
Hashemi S; Aghamiri MR; Kahani M; Jaberi R
Int J Nanomedicine; 2019; 14():4157-4165. PubMed ID: 31239674
[No Abstract] [Full Text] [Related]
10. Perturbation of TG-43 parameters of the brachytherapy sources under insufficient scattering materials.
Zehtabian M; Sina S; Faghihi R; Meigooni A
J Appl Clin Med Phys; 2013 May; 14(3):4228. PubMed ID: 23652255
[TBL] [Abstract][Full Text] [Related]
11. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
Melhus CS; Rivard MJ
Med Phys; 2008 Jul; 35(7):3364-71. PubMed ID: 18697560
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
13. Dose rate constants for 125I, 103Pd, 192Ir and 169Yb brachytherapy sources: an EGS4 Monte Carlo study.
Mainegra E; Capote R; López E
Phys Med Biol; 1998 Jun; 43(6):1557-66. PubMed ID: 9651025
[TBL] [Abstract][Full Text] [Related]
14. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
15. Radial dose functions for 103Pd, 125I, 169Yb and 192Ir brachytherapy sources: an EGS4 Monte Carlo study.
Mainegra E; Capote R; López E
Phys Med Biol; 2000 Mar; 45(3):703-17. PubMed ID: 10730965
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
[TBL] [Abstract][Full Text] [Related]
18. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
Lesperance M; Inglis-Whalen M; Thomson RM
Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
[TBL] [Abstract][Full Text] [Related]
19. Improvement of dose distribution in ocular brachytherapy with
Zabihzadeh M; Rezaee H; Hosseini SM; Feghhi M; Danyaei A; Hoseini-Ghahfarokhi M
J Cancer Res Ther; 2019; 15(3):504-511. PubMed ID: 31169211
[TBL] [Abstract][Full Text] [Related]
20. Gamma irradiation of ocular melanoma and lymphoma cells in the presence of gold nanoparticles: in vitro study.
Kanavi MR; Asadi S; Balagholi S; Alikarami F; Nosrati H; Ahmadieh H
J Appl Clin Med Phys; 2018 May; 19(3):268-275. PubMed ID: 29707895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
